High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in the Netherlands: Identification and characterization of eight novel mutations

Autor: John J.P. Kastelein, Jan Albert Kuivenhoven, Frank Peelman, M. Mahdi Motazacker, Alinda W. M. Schimmel, Jorge Peter, Adriaan G. Holleboom, Joep C. Defesche, G. Kees Hovingh, Erik S.G. Stroes
Přispěvatelé: Vascular Medicine, Amsterdam Cardiovascular Sciences, Experimental Vascular Medicine, Human Genetics
Rok vydání: 2011
Předmět:
Zdroj: Human mutation, 32(11), 1290-1298. Wiley-Liss Inc.
ISSN: 1059-7794
DOI: 10.1002/humu.21578
Popis: Lecithin:cholesterol acyltransferase (LCAT) is crucial to the maturation of high-density lipoprotein (HDL). Homozygosity for LCAT mutations underlies rare disorders characterized by HDL-cholesterol (HDL-c) deficiency while heterozygotes have half normal HDL-c levels. We studied the prevalence of LCAT mutations in referred patients with low HDL-c to better understand the molecular basis of low HDL-c in our patients. LCAT was sequenced in 98 patients referred for HDL-c T (p.E134D), c.403T>A (p.Y135N), c.964C>T (p.R322C), c.296G>C (p.W99S), c.736G>T (p.V246F), c.802C>T (p.R268C), c.945G>A (p.W315X), c.1012C>T (p.L338F), and c.1039C>T (p.R347C)--were shown to be functional through in vitro characterization. The effect of several mutations on the core protein structure was studied by a three-dimensional (3D) model. Unlike previous reports, functional mutations in LCAT were found in 29% of patients with low HDL-c, thus constituting a common cause of low HDL-c in referred patients in The Netherlands
Databáze: OpenAIRE